Irlab Therapeutics Ab Class A

IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)

IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease

The European Patent Office Intends to Grant a New Patent for IRLAB's Mesdopetam

IRLAB Appoints Gustaf Albèrt as the New Chief Financial Officer

IRLAB Progresses Fully Funded IRL757 Study in Parkinson's Disease in Partnership with MSRD